Financial Report
The consolidated financial statements include the financial statements of the Company and the subsidiaries listed below. Details of investments in subsidiaries as at 31 December are as follows:
|
Name |
Location |
Percentage of ownership |
|
|
|
|
2023 |
2022 |
|
|
|
|
|
|
Polypeptide Laboratories Holding (PPL) AB |
Limhamn, Sweden |
100% |
100% |
|
Polypeptide Laboratories (Sweden) AB |
Limhamn, Sweden |
100% |
100% |
|
PolyPeptide SA |
Braine-l’Alleud, Belgium |
100% |
100% |
|
PolyPeptide Laboratories France S.A.S. |
Strasbourg, France |
100% |
100% |
|
PolyPeptide Laboratories Inc. |
Torrance, CA, USA |
100% |
100% |
|
PolyPeptide Laboratories San Diego, LLC 1 |
San Diego, CA, USA |
100% |
100% |
|
PolyPeptide Laboratories Pvt. Ltd. |
Ambernath (East), India |
100% |
100% |
|
PolyPeptide Laboratories A/S 2 |
Hillerød, Denmark |
100% |
100% |
1 PolyPeptide Laboratories San Diego, LLC is a wholly owned subsidiary of PolyPeptide Laboratories Inc.
2 PolyPeptide Laboratories A/S is a dormant company.
Percentage of voting shares is equal to percentage of ownership.